Home › Castration-Resistant Prostatic Cancer › New Jersey
Pag-aaral pangklinika para sa Castration-Resistant Prostatic Cancer sa New Jersey
4 pag-aaral para sa Castration-Resistant Prostatic Cancer ang naghahanap ng mga kalahok sa mga site sa New Jersey.
Opisyal na teksto ng pag-aaral (English)
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Astera Cancer Care, East Brunswick
- Rutgers Cancer Institute of New Jersey, New Brunswick
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07225946A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- START New Jersey, East Brunswick
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Set 24, 2026 · NCT07719361A Study of Real-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC Patients Previously Treated With an Androgen Receptor Pathway Inhibitor, Taxane-Based Chemotherapy, and Lutetium-177 Vipivotide Tetraxetan
- Novartis, East Hanover
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 115 · Kalalakihan · Na-update Hul 16, 2026 · NCT07677267A Study of Real-World Characteristics, Treatment Patterns, and Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer
- Novartis, East Hanover
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 115 · Kalalakihan · Na-update Hul 16, 2026 · NCT07677254Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.